Exosome Medical
Evidence-Based Research

Research & Publications

Pear-reviewed studies and clinical evidence supporting the therapeutic potential of iPS-derived exosomes.

50+

Publications

9k+

Citations

20+

Years

OUR PROGRESS

Research Pipeline

Discovery

Target identification

In Vitro

Cell culture studies

3

Preclinical

Animal studies

In Progress
4

Phase I

Safety trials

5

Phase II/III

Efficacy studies

PEER REVIEWED

Publications

OsteoarthritisAnimal Study2022

iPSC-derived exosomes promote cartilage regeneration in osteoarthritis model.

Hsueh YH, Buddhakosai W, Le PN, et al.

J Orthop Translat. 38:141-155

Cellular SenescenceIn Vitro2018

Exosomes derived from human induced pluripotent stem cells ameliorate the aging of skin fibroblasts.

Oh M, Lee J, Kim YJ, et al.

Int J Mol Sci. 19(6):1715

Cellular SenescenceIn Vitro2019

Highly purified human extracellular vesicles produced by stem cells alleviate aging cellular phenotypes.

Liu S, Mahairaki V, Bai H, et al.

Stem Cells. 37(6):779-790

MechanismIn Vitro2020

Exosomes derived from iPSCs deliver functional proteins to target cells.

Wang Y, Zhang L, Li Y, et al.

J Cell Mol Med. 24(8):4336-4347

METHODOLOGY

Research Standards

In Vitro Studies

Cell culture experiments examining exosome uptake, mechanism of action, and dose-response relationships.

Animal Models

Validated disease models with standardized endpoints, blinded analysis, and GLP compliance.

Quality Assurance

GMP manufacturing, IRB oversight, pre-registered protocols, and independent monitoring.

OUR COMMITMENT

Transparency in Research

We publish all results—positive and negative—to advance scientific understanding and maintain the highest ethical standards.

ClinicalTrials.gov registration
Pre-registered primary endpoints
Open access publication
Full data availability
100%

Results Published

All studies, regardless of outcome, are submitted for peer review.

Partner With Us

We welcome collaborations with academic institutions, research organizations, and industry partners.

Start a Conversation